Artificial Intelligence

Houston is one of seven global Precision specialty labs addressing the rising demand for rapid, comprehensive biomarker data to support the development of advanced therapies and diagnostics HOUSTON, April 11, 2023 /PRNewswire/ -- Precision...

Invitation from Deep Bio: Our team is ready to greet you at booth #3445! Find out how DeepDx® Prostate empowers pathologists. Also, Deep Bio will present two research abstracts in relation to biomarker in prostate and breast cancers at...

PathAI PathExplore™ panel will empower oncology drug developers with improved tumor microenvironment spatial characterization from H&E, propelling a new phase of precision medicine. BOSTON, April 4, 2023 /PRNewswire/ -- PathAI, a...

Nijmegen, Netherlands – Aiosyn, a medical software company that develops AI-powered pathology solutions, has been awarded a 1,6M € Eurostars grant together with Pathomation and Radboud University Medical Center to accelerate the development...

Andy Beck of PathAI: AI will continue to get better over time. Systems are continually improving and will be considerably more advanced looking ahead just five years from now. This expectation of progress gives us in the AI industry optimism...

Leica Biosystems: The BOND MMR Antibody Panel is now available for clinical use on BOND-III and BOND-MAX Immunohistochemistry (IHC) automated instruments. NEWCASTLE, UK – Leica Biosystems today announced the US Food and Drug...